With 60+ years of drug development and healthcare industry expertise combined, our team will work alongside of the founders on a mission to extend human health-span beyond 100


  • Founding General Partner

    Zheng has 9 years of drug development and commercialization expertise with 7 years of venture investing, and a network of longevity clinicians and researchers to target aging and extending human health-span.


  • Venture Partner

    Barker's 25-year business career has spanned biopharmaceuticals, diagnostics and bioinformatics – both in the USA and EU, focused on accelerating the translation of therapeutics with the potential to improve healthy lifespan on a global scale.


  • Venture Partner

    Gamelin is a globally-recognized leader of Oncology and Hematology research and development with extensive expertise applying scientific and clinical vision to formulate and execute new research strategies. Dr. Gameline has brought six drugs from early clinical development through FDA approval.


  • Entrepreneur in Residence

    Rios is a molecular scientist graduated from Stanford with experience in neuroscience, metabolism, immune resilience, and drug development.